Augmedix Inc

Augmedix — JMP Securities Technology Conference 2022

14 slides from Augmedix's conference presentation, Mar 8, 2022

  1. Slide 1: Investor Presentation – JMP Securities Technology Conference

    Investor Presentation JMP Securities Technology Conference San Francisco M a r c h 8 , 2 0 2 2

  2. Slide 2: Forward-looking statements

    This presentation includes forward-looking statements . All statements other than statements of historical facts contained in these materials or elsewhere, including statements regarding the Company’s future financial position, business strategy and plans and objectives of management for future oper

  3. Slide 3: Introductions

    3 Emmanuel Krakaris Chief Executive Officer • 25 years experience • Joined Augmedix in 2018 Prior experience: Paul Ginocchio Chief Financial Officer • 23 years experience • Joined Augmedix in 2020 Prior experience: Introductions

  4. Slide 4: Augmedix at a Glance

    4 Augmedix at a Glance Real - time and asynchronous virtual medical documentation for clinicians Connect clinicians with Augmedix Ambient Automation Platform through mobile devices and proprietary software Comprehensive and flexible solution capable of being delivered at scale to > 50 , 000 addressa

  5. Slide 5: Key Healthcare Macro Tailwinds

    5 Key Healthcare Macro Tailwinds • Leading to increased demand to reduce EHR burden • Driving more investments in digital solutions • Accelerating adoption for virtual documentation GROWING DOCTOR BURNOUT AND STAFFING SHORTAGES HEALTH SYSTEMS’ RISING NEED FOR INCREASED EFFICIENCY AND CAPACITY AT SCA

  6. Slide 6: Augmedix Eases the EHR Burden on Providers & Creates System Efficiencies

    Livestream Electronic Health Record Medical documentation uploaded for the physician’s sign - off PHYSICIAN P ATIENT Natural Conversation • In exam room • Virtual visits / telemedicine • Automation technology & domain expertise • Real - time & synchronous communication Enhanced Documentation AUGMEDI

  7. Slide 7: Driving a $6 Billion Market Opportunity for Augmedix

    (1) Company estimates out of a total of more than 1.1M U.S. Clinicians. 7 Select Current Customers >50,000 (1) Addressable Physicians Major Health Systems O p por t u n i t y ~295,000 (1) Addressable Physicians in U.S. $6B U.S. Market Opportunity $1B+ Expansion Opportunity within Existing Customers

  8. Slide 8: Real-Time and Asynchronous Offerings Provide Flexibility and Expand the TAM

    8 Real - Time and Asynchronous Offerings Provide Flexibility, Expand the TAM, and Generate a High - Win Rate vs Competitors Coding Su pp o rt Re m in d er Support Order Su pp o rt Medical D o cum e n ta t ion 2014 Launch 2020 Launch Live In real - time Notes Medical Documentation Prior to next shift

  9. Slide 9: Key Customer Wins in 2021 & Early 2022

    9 Veterinary ER with multiple follow - on expansions Notes: Competitive win with national oncology provider Live: Competitive win vs asynchronous solution with rural health system Large regional health system in top 10 U.S. city ER pilot with a top 20 health system Key Customer Wins in 2021 & Early

  10. Slide 10: Augmedix Ambient Automation Platform

    Augmedix Ambient Automation Platform 10 EHR Inte g r at i on ambient c o n ver sat ion E H R Messages Reminders E HR Builder Manager P r efe r e n ces Notebuilder Au g m ed ix NLP ASR+ Medical Note Chart Prep AVS Coding • Building Block approach combines: o Automated Speech Recognition o Natural Lan

  11. Slide 11: Medical Note Data Flow

    Medical Note Data Flow NOTEBUILDER NOTE TRANSCRIPT 11

  12. Slide 12: Note: Fiscal years are audited through December 31, 2020. Quarterly results are unaudited. (1)

    Note: Fiscal years are audited through December 31, 2020. Quarterly results are unaudited. (1) Q4 2021 figure and related growth rate based on preliminary, unaudited estimates announced on January 31, 2022, and reflects the midpoint of the range expected for Q4 2021. By this presentation, Augmedix i

  13. Slide 13: Highly Experienced Management Team

    Emmanuel Krakaris Chief Executive Officer Highly Experienced Management Team Sandra Breber Chief Operating Officer Ian Shakil Co - F o u nde r & Chief Strategy Officer Davin Lundquist, MD Chief Medical Officer Paul Ginocchio Chief Financial Officer Jonathan Hawkins Chief Revenue Officer Saurav Chatt

  14. Slide 14: Investment Highlights

    14 Investment Highlights Differentiated and flexible product solutions for virtual documentation: Ambient, Mobile, Remote, Real - Time & Synchronous Increasing physician productivity and optimizing reimbursement Building on AI - driven core platform to deliver automated add - ons and drive growth Le

Augmedix — JMP Securities Technology Conference 2022 on 6ix